Translating Science into Breakthrough Therapies

Boehringer Ingelheim strives to deliver novel and transformative therapeutic targets in the fight against cancer. We are designing smart combinations of immuno-oncology and cancer cell directed therapies to take cancer on, address current treatment challenges and the unmet needs of patients, in some of the most difficult-to-treat cancers.

Note: This webpage hosts content for general public as well as for  healthcare professional and journalists & media professionals. To be able to see and access respective content you need to select your profession through the filter button on the right.